Yes. Ipsen was formerly owned by 2 private investors.
Ipsen is headquartered in Boulogne-Billancourt, France.
Ipsen disclosed revenue of 3,575M EUR for 2024 and 3,306M EUR for 2023.
Ipsen has 5,358 employees.
Ipsen is a life science company.
Ipsen was founded in 1929.
65, quai Georges Gorse Cedex,
Boulogne-Billancourt,
92100
France,
+33 1 58 33 50 00
www.ipsen.com
Ipsen is a research and development pharmaceutical company. It manufactures specialty pharmaceuticals and has a worldwide sales presence. Ipsen focuses on products in the gastro-enterology, neurology and cardiovascular therapeutic areas and has also developed specific expertise in some biotech niches such as endocrinology, oncology, neurology and hematology. Ipsen was founded in 1929 and is based in Boulogne-Billancourt, France.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.6/yr) | # | 9 | - | 1 | 1 | - | 1 | 12 |
| vol | $1.1B | $247M | $952M | $2.3B | ||||
| Sell (0.4/yr) | # | - | 1 | 1 | - | - | - | 2 |
| 14 | ||||||||
| Financial | Deals |
|---|---|
|
Barclays Investment Bank |
1 |
|
Centerview Partners |
1 |
|
Goldman Sachs |
1 |
| Legal | Deals |
|---|---|
|
Orrick |
2 |
|
A&O Shearman |
1 |
|
Dechert |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
